Trial Profile
Effectiveness After Four and Twentyfour Weeks and Safety of Tocilizumab in Patients With Active RA.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 18 Dec 2009 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 18 Dec 2009 Actual patient number (332) added as reported by ClinicalTrials.gov.
- 18 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.